Blackhawk Plastic Surgery and other practices report a significant uptick in body-contouring procedures, directly attributable to the GLP-1 agonist boom. Patients losing 50+ pounds on semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro) are seeking skin-tightening, cellulite reduction, and body-sculpting treatments to address loose skin and contour irregularities—a natural follow-on to weight loss.
Market
GLP-1 Weight-Loss Boom Fuels Body-Contouring Volume — Practices Report Surge in Post-Weight-Loss Procedures
Ozempic/Wegovy patients driving demand for skin-tightening and body-sculpting treatments.
